Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

17
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
17
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

17
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
17
Drug Delivery: Overview01:16

Drug Delivery: Overview

937
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
937
Modified-Release Drug Delivery Systems: Influencing Factors01:20

Modified-Release Drug Delivery Systems: Influencing Factors

20
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
20
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

18
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

20
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
20

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Niclosamide Encapsulated pH-Responsive Polyzwitterionic Block Copolymers for Cancer Therapy.

Macromolecular bioscience·2026
Same author

Ponatinib Averts αCD40 Antibody Mediated Toxicity by Lowering MAPK38 Expression and Shows Proimmunogenic Effects in a Murine Tumor Model.

ACS pharmacology & translational science·2025
Same author

Controller design for an approximated nonlinear system using Wavelet Transform.

ISA transactions·2025
Same author

A glucose-responsive alginate-based hydrogel laden with modified GLP-1 and telmisartan ameliorates type 2 diabetes and reduces liver and kidney toxicities.

Journal of materials chemistry. B·2025
Same author

Alleviating hypoxia and oxidative stress for treatment of cardiovascular diseases: a biomaterials perspective.

Journal of materials chemistry. B·2024
Same author

Encapsulation of telmisartan inside insulinoma-cell-derived extracellular vesicles outperformed biomimetic nanovesicles in modulating the pancreatic inflammatory microenvironment.

Journal of materials chemistry. B·2024

関連する実験動画

Updated: Feb 17, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K

デング熱ワクチンの開発における課題を克服する:先進的な配給アプローチ

Anindita Sengupta1,2, Jayanta Bhattacharyya1,2

  • 1Centre for Biomedical Engineering, Indian Institute of Technology, Delhi, New Delhi 110016, India.

Molecular pharmaceutics
|February 16, 2026
PubMed
まとめ

効果的なデング熱ワクチンの開発は,免疫学的障壁のために困難です. 先進的な抗原設計,ナノ粒子配送システム,強力な補助剤などの新しい戦略は,すべてのデング熱ウイルス (DENV) 血清型に対して持続的な保護のために,ワクチンによって誘発された免疫記憶を改善することを目的としています.

キーワード:
TLRアゴニスト先進的な配送システム細胞フリーワクチンです.デング熱ワクチンの接種ハイドロゲルとは免疫調節剤 免疫調節剤は免疫を調節する.in silico モデルにしました.ナノ粒子 ナノ粒子持続的な放出による.

さらに関連する動画

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K

関連する実験動画

Last Updated: Feb 17, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K

科学分野:

  • 免疫学 免疫学とは
  • ワクチン学 ワクチン学
  • バイオテクノロジー バイオテクノロジー

背景:

  • デング熱ウイルス (DENV) は,4つの異なる血清型で,世界的な健康に重大な脅威をもたらしています.
  • 既存のワクチン開発は,抗体依存増強 (ADE),原始抗原性罪,そしてバランスのとれた長期間続く免疫の達成などの障害に直面しています.
  • これらの免疫的障壁を克服することは,安全で効果的なデング熱ワクチンの作成に不可欠です.

研究 の 目的:

  • ワクチンによるデング熱に対する免疫記憶の強化のための新興戦略を見直す.
  • 合理的な抗原設計と,より優れたデング熱ワクチンのための高度な配送システムを探求する.
  • デング熱ワクチンの開発における課題に対処する革新的なアプローチを強調する.

主な方法:

  • ナノ粒子ベースの配送システム (脂質,ポリマー,VLP) に関する現在の研究のレビュー.
  • 注射用ヒドロゲル,反応性バイオマテリアル,および標的型投与システムの分析.
  • 強力な補助剤 (TLRアゴニスト,サポニン) と新しいワクチンプラットフォーム (mRNA,DNA,EV) の評価.
  • エピトープ識別と免疫応答シミュレーションのためのin silicoアプローチの含有.

主要な成果:

  • ナノ粒子は,抗原の安定性, dendritic 細胞の吸収,リンパ節の配送を強化します.
  • バイオマテリアルから持続的な抗原の放出は,生殖中心の形成と記憶B/T細胞の反応を促進します.
  • 標的型投与と強力な補助剤は,抗原プレゼンテーションを改善し,Th1型応答を誘導します.
  • mRNA,DNA,EVなどの新しいプラットフォームは,スケーラブルで免疫活性化ソリューションを提供しています.

結論:

  • 抗原設計と配送システムの新興戦略は,デング熱ワクチンの課題を克服する見込みを示しています.
  • これらのアプローチは,すべてのDENV血清型に対して,堅牢でバランスの取れた,長期にわたる免疫を誘導することを目的としています.
  • 集団的な進歩は,より安全で効果的なデング熱ワクチンの開発を支援しています.